Novel drug delivery system produced by centrifugal technologies – composed to minimize adverse immune reactions and designed for optimised therapeutic effects

Project Information

DECENT AID

Grant agreement ID: 324275

Project closed

Start date 1 April 2013

End date 31 March 2017

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 1 492 545,10

EU contribution € 1 492 545,10

Coordinated by

ABNOBA GMBH
Germany